Lisa Peraza
Fortuna: 107 550 $ al 30/06/2026
Fortuna: 107 550 $ al 30/06/2026
Lisa Peraza is Vice President-Finance at Connect Biopharma Holdings Ltd. since 2024.
Formerly, Ms. Peraza was Chief Accounting Officer & Vice President at Heron Therapeutics, Inc. from 2020 to 2024 and Executive Director & Controller at Ardea Biosciences, Inc. from 2008 to 2014.
Education includes undergraduate studies at the University of California, Santa Barbara.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/03/2026 | 45.189 ( 0,08 % ) | 107 550 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Director Financiero/CFO | 13/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| HERON THERAPEUTICS, INC. | Director Administrativo | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Director/Miembro de la Junta | 01/03/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.